Clinical Trials

SonoLysis^™+tPA Therapy
Phase I / II study evaluating our proprietary MRX-801 microbubbles, ultrasound and tPA for the treatment of acute ischemic stroke.

ImaRx is conducting an immunogenicity trial with Abbokinase^® to evaluate patients' immune response to this marketed product.